Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet

British Journal of Nutrition

Volumn 106, Issue 10, 2011, Pages 1495-1505

  Lucas, Edralin A ^a   Li, Wenjia ^a   Peterson, Sandra K ^a   Brown, Angela ^a   Kuvibidila, Solo ^a   Perkins Veazie, Penny ^b   Clarke, Stephen L ^a   Smith, Brenda J ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Cholesterol; Diabetes; Glucose; High fat diet; Mango

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE ALPHA; ACYL COENZYME A OXIDASE; ADIPONECTIN; CHOLESTEROL; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORT PROTEIN 5; FATTY ACID TRANSPORTER; FENOFIBRATE; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACETYL COENZYME A CARBOXYLASE ALPHA GENE; ACYL COENZYME A OXIDASE GENE; ADIPOCYTE P2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPIDIDYMIS FAT; FATTY ACID TRANSPORT PROTEIN 5 GENE; FOOD COMPOSITION; FREEZE DRIED MANGO PULP; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER 4 GENE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; MANGO; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE GENE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADIPOSITY; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; DIETARY FATS; GENE EXPRESSION PROFILING; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; MANGIFERA; MICE; MICE, INBRED C57BL; ORGAN SIZE; REAL-TIME POLYMERASE CHAIN REACTION;

MUS;

EID: 80755169026     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002066     Document Type: Article

References (55)

1. Flegal KM, Carroll MD, Ogden CL, et al. (2010) Prevalence and trends in obesity among US adults. 1999-2008. JAMA 303, 235-241.
2. Popkin BM (2001) The nutrition transition and obesity in the developing world. J Nutr 31, 871S-873S. (Pubitemid 32201175)
3. American Heart Association (2010) Heart and stroke facts: statistical update. 2010 Report. http://www.americanheart.org/downloadable/heart/ 1265665152970DS-3241%20Heart-StrokeUpdate-2010.pdf
4. American HeartAssociation. International cardiovascular disease statistics. Statistical fact sheet 2009 update. http://americanheart. org/downloadable/heart/1236204012112INTL.pdf
5. Mathieu P, Lemieux I & Després JP (2010) Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87, 407-416.
6. Siri-Tarino PW, Sun Q, Hu FB, et al. (2010) Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 91, 502-509.
7. Hanna-Moussa A, Gardner MJ, Kurukulasuriya LR, et al. (2009) Dysglycemia/prediabetes and cardiovascular risk factors. Rev Cardiovasc Med 10, 202-208.
8. Robinson E & Grieve DJ (2009) Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease. Pharmacol Ther 122, 246-263.
9. Wang YX (2010) PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 20, 124-137.
10. Latruffe N & Vamecq J (1997) Peroxisome proliferators and peroxisome proliferator activated receptors as regulators of lipid metabolism. Biochimie 79, 81-94. (Pubitemid 27290347)
11. Kalaitzidis RG, Sarafidis PA & Bakris GL (2009) Effects of thiazolidinediones beyond glycaemic control. Curr Pharm Des 15, 529-536.
12. Roberts WC (1989) Safety of fenofibrate-US and worldwide experience. Cardiology 76, 169-179.
13. Ullah MF & Khan MW (2008) Food as medicine: potential therapeutic tendencies of plant derived polyphenolic compounds. Asian Pac J Cancer Prev 9, 187-195.
14. Jew S, AbuMweis SS & Jones PJ (2009) Evolution of the human diet: linking our ancestral diet to modern functional foods as a means of chronic disease prevention. J Med Food 12, 925-934.
15. Jayaprakasam B, Vareed SK, Olson LK, et al. (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53, 28-31. (Pubitemid 40066465)
16. Ware WR (2009) Nutrition and the prevention and treatment of cancer: association of cytochrome P450 CYP1B1 with the role of fruit and fruit extracts. Integr Cancer Ther 8, 22-28.
17. Wu H, Dai Q, Shrubsole MJ, et al. (2009) Fruit and vegetable intakes are associated with lower risk of colorectal adenomas. J Nutr 139, 340-344.
18. Iriti M & Faoro F (2006) Grape phytochemicals: a bouquet of old and new nutraceuticals for human health. Med Hypotheses 67, 833-838. (Pubitemid 44062136)
19. U.S. Department of Agriculture & Agricultural Research Service (2005) USDA National nutrient database for standard reference, Release 18. http://www.ars.usda.gov/ba/bhnrc/ndl
20. Ojewole JA (2005) Antiinflammatory, analgesic and hypoglycemic effects of Mangifera indica Linn. (Anacardiaceae) stem-bark aqueous extract. Methods Find Exp Clin Pharmacol 27, 547-554. (Pubitemid 41727528)
21. Muruganandan S, Srinivasan K, Gupta S, et al. (2005) Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97, 497-501. (Pubitemid 40312325)
22. Aderibigbe AO, Emudianughe TS & Lawal BAS (2001) Evaluation of the antidiabetic action of Mangifera indica in mice. Phytother Res 15, 456-458. (Pubitemid 32762401)
23. Aderibigbe AO, Emudianughe TS & Lawal BAS (1999) Antihyperglycaemic effect of Mangifera indica in rat. Phytother Res 13, 504-507. (Pubitemid 29445769)
24. Percival SS, Talcott ST, Chin ST, et al. (2006) Neoplastic transformation of BALB/3T3 cells and cell cycle of HL-60 cells are inhibited by mango (Mangifera indica L.) juice and mango juice extracts. J Nutr 136, 1300-1304.
25. Wilkinson AS, Monteith GR, Shaw PN, et al. (2008) Effects of the mango components mangiferin and quercetin and the putative mangiferin metabolite norathyriol on the transactivation of peroxisome proliferator-activated receptor isoforms. J Agric Food Chem 56, 3037-3042. (Pubitemid 351746026)
26. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951. (Pubitemid 23342492)
27. Molnar J, Yu S, Mzhavia N, et al. (2005) Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 96, 1178-1184. (Pubitemid 40827693)
28. Manthey J & Perkins-Veazie P (2009) Influences of harvest date and location on the levels of beta-carotene, ascorbic acid, total phenols, the in vitro antioxidant capacity, and phenolic profiles of five commercial varieties of mango (Mangifera indica L.). J Agric Food Chem 57, 10825-10830.
29. Lucas EA, Juma S, Stoecker BJ, et al. (2000) Prune suppresses ovariectomy-induced hypercholesterolemia in rats. J Nutr Biochem 11, 255-259. (Pubitemid 30392410)
30. Prior RL, Wu X, Gu L, et al. (2008) Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem 56, 647-653. (Pubitemid 351300226)
31. Dulebohn RV, Yi W, Srivastava A, et al. (2008) Effects of blueberry (Vaccinium ashei) on DNA damage, lipid peroxidation, and phase II enzyme activities in rats. J Agric Food Chem 56, 11700-11706.
32. Bobek P, Ginter E, Jurcovicova M, et al. (1990) Effect of dehydrated apple products on the serum and liver lipids in Syrian hamsters. Nahrung 34, 783-789.
33. Chao L, Marcus-Samuels B, Mason MM, et al. (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106, 1221-1228.
34. Guerre-Millo M, Gervois P, Raspé E, et al. (2000) Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275, 16638-16642. (Pubitemid 30398891)
35. Tai MM (1994) A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17, 152-154. (Pubitemid 24035313)
36. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
37. Lee S, Muniyappa R, Yan X, et al. (2008) Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. Am J Physiol Endocrinol Metab 294, E261-E270. (Pubitemid 351231452)
38. Valasek MA, Clarke SL & Repa JJ (2007) Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. J Lipid Res 48, 2725-2735. (Pubitemid 350272857)
39. Prior RL, Wilkes S, Rogers T, et al. (2010) Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J Agric Food Chem 58, 3970-3976.
40. Fukumitsu S, Aida K, Ueno N, et al. (2008) Flaxseed lignin attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 100, 669-676.
41. Yoon M, Jeong S, Nicol CJ, et al. (2002) Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism. Exp Mol Med 34, 481-488. (Pubitemid 36114367)
42. Mancini FP, Lanni A, Sabatino L, et al. (2001) Fenofibrate prevents and reduced body weight gain and adiposity in diet-induced obese rats. FEBS Lett 491, 154-158. (Pubitemid 32172021)
43. Nagai Y, Nishio Y, Nakamura T, et al. (2002) Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am J Physiol Endocrinol Metab 282, E1180-E1190. (Pubitemid 34654734)
44. Kuda O, Jelenik T, Jilkova Z, et al. (2009) n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52, 941-951.
45. Caldwell J (1989) The biochemical pharmacology of fenofibrate. Cardiology 76, 33-41.
46. Walker GE, Marzullo P, Verti B, et al. (2008) Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects. Obesity (Silver Spring) 16, 1983-1991.
47. Larsen TM, Toubro S & Astrup A (2003) PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27, 147-161. (Pubitemid 36255796)
48. Contractor Z, Hussain F & Jabbar A (1999) Postprandial glucose response to mango, banana and sapota. J Pak Med Assoc 49, 215-216.
49. Roongpisuthipong C, Banphotkasem S, Komindr S, et al. (1991) Postprandial glucose and insulin responses to various tropical fruits of equivalent carbohydrate content in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 14, 123-131.
50. Parmar H & Kar A (2007) Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxantreated male mice. Biofactors 31, 17-24. (Pubitemid 352032102)
51. Xie W, Nie Y, Du L, et al. (2007) Preventive effects of fenofibrate on insulin resistance, hyperglycaemia, visceral fat accumulation in NIH mice induced by small-dose streptozotocin and lard. Pharmacol Res 55, 392-399. (Pubitemid 46560391)
52. Srivastava RA (2009) Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPARgamma, and liver £ receptor agonists. Eur J Pharmacol 607, 258-263.
53. Arai T, Kim HJ, Chiba H, et al. (2009) Interaction of fenofibrate and fish oil in relation to lipid metabolism in mice. J Atheroscler Thromb 16, 283-291.
54. Declercq V, Yeganeh B, Moshtaghi-Kashanian GR, et al. (2005) Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice. J Cardiovasc Pharmacol 46, 18-24. (Pubitemid 40917774)
55. Mancini FP, Lanni A, Sabatino L, et al. (2001) Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett 491, 154-158. (Pubitemid 32172021)